Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tetracaine for Corneal Abrasions
NCT02771392Phase 3Unknown
- Sponsor
- NewYork-Presbyterian Brooklyn Methodist Hospital
- Start
- Jun 2016
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of tetracaine in corneal abrasion (2 arms), sponsored by NewYork-Presbyterian Brooklyn Methodist Hospital. Primary endpoint: Pain assessed with Visual Analog Scale at 48 hours. Status: unknown.
02
Drugs
tetracaine
03
Conditions
corneal abrasion
Beyond the preview
Go deeper on NCT02771392.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02771392.